40 related articles for article (PubMed ID: 29943692)
1. Plantarflexor weakness negatively impacts walking in persons with multiple sclerosis more than plantarflexor spasticity.
Wagner JM; Kremer TR; Van Dillen LR; Naismith RT
Arch Phys Med Rehabil; 2014 Jul; 95(7):1358-65. PubMed ID: 24582617
[TBL] [Abstract][Full Text] [Related]
2. Effect of cryotherapy in controlling spasticity of calf muscles in patients with multiple sclerosis.
Abdelhakiem NM; Mahmoud TH; Saleh HM; Alsaid HM; Salem S; El Semary MM
NeuroRehabilitation; 2024; 54(4):653-661. PubMed ID: 38875049
[TBL] [Abstract][Full Text] [Related]
3. Impact of Massage Therapy on Fatigue, Pain, and Spasticity in People with Multiple Sclerosis: a Pilot Study.
Backus D; Manella C; Bender A; Sweatman M
Int J Ther Massage Bodywork; 2016 Dec; 9(4):4-13. PubMed ID: 27974947
[TBL] [Abstract][Full Text] [Related]
4. A group-delivered self-management program reduces spasticity in people with multiple sclerosis: A randomized, controlled pilot trial.
Hugos CL; Bourdette D; Chen Y; Chen Z; Cameron M
Mult Scler J Exp Transl Clin; 2017; 3(1):2055217317699993. PubMed ID: 28607753
[TBL] [Abstract][Full Text] [Related]
5. Development of an integrated conceptual model of multiple sclerosis spasticity.
Cameron MH; Bethoux F; Field-Fote E; Lenderking WR; Zaiser E; Cutts KN; Wagner JM; Berwaerts J; Steinerman JR
Disabil Rehabil; 2024 Jun; 46(13):2955-2965. PubMed ID: 37480330
[TBL] [Abstract][Full Text] [Related]
6. Cryoneurolysis of the Femoral Nerve for Focal Spasticity in an Ambulatory Patient.
Boissonnault È; MacRae F; Hashemi M; Bursuc A; Winston P
Arch Rehabil Res Clin Transl; 2024 Mar; 6(1):100319. PubMed ID: 38482108
[TBL] [Abstract][Full Text] [Related]
7. Recognition, Description, and Variability of Spasticity in Individuals With Multiple Sclerosis and Potential Barriers to Clinician-Patient Dialogue: Results From SEEN-MSS, a Large-Scale, Self-Reported Survey.
Thrower B; Newsome SD; Hendin B; Danese S; Patterson J; Chinnapongse R
Int J MS Care; 2024; 26(2):75-80. PubMed ID: 38482511
[TBL] [Abstract][Full Text] [Related]
8. Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis.
Fernández Fernández Ó; Costa-Frossard L; Martínez Ginés ML; Montero Escribano P; Prieto González JM; Ramió-Torrentà L; Aladro Y; Alonso Torres A; Álvarez Rodríguez E; Labiano-Fontcuberta A; Landete Pascual L; Miralles Martínez A; Moral Torres E; Oliva-Nacarino P
Front Neurol; 2024; 15():1371644. PubMed ID: 38708001
[TBL] [Abstract][Full Text] [Related]
9. In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study.
Valko PO; Roschitzki B; Faigle W; Grossmann J; Panse C; Biro P; Dambach M; Spahn DR; Weller M; Martin R; Baumann CR
J Sleep Res; 2019 Jun; 28(3):e12721. PubMed ID: 29961995
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis: severe exacerbation after stopping disease-modifying drugs.
Członkowska A; Mirowska-Guzel D
Eur J Neurol; 2018 Oct; 25(10):1199-1200. PubMed ID: 29959813
[No Abstract] [Full Text] [Related]
11. Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study.
D'Amico E; Patti F; Zanghì A; Chisari CG; Lo Fermo S; Zappia M
Eur J Neurol; 2018 Dec; 25(12):1425-1431. PubMed ID: 29956427
[TBL] [Abstract][Full Text] [Related]
12. What's new in multiple sclerosis?
Tillery EE; Clements JN; Howard Z
Ment Health Clin; 2017 Sep; 7(5):213-220. PubMed ID: 29955526
[TBL] [Abstract][Full Text] [Related]
13. Spinal cord volume loss: A marker of disease progression in multiple sclerosis.
Tsagkas C; Magon S; Gaetano L; Pezold S; Naegelin Y; Amann M; Stippich C; Cattin P; Wuerfel J; Bieri O; Sprenger T; Kappos L; Parmar K
Neurology; 2018 Jul; 91(4):e349-e358. PubMed ID: 29950437
[TBL] [Abstract][Full Text] [Related]
14. Phase III SUNBEAM and RADIANCE PART B trials for Ozanimod in relapsing multiple sclerosis demonstrate superiority versus interferon-β-1a (Avonex
Koscielny V
Neurodegener Dis Manag; 2018 Jun; 8(3):141-142. PubMed ID: 29943693
[TBL] [Abstract][Full Text] [Related]
15. Increases in fatigue do not change spasticity scores in persons with multiple sclerosis.
Karpatkin H; Babyar S; DiCarrado S; McDarby M; Narovlianski M; Perez B; Rimawi I
Neurodegener Dis Manag; 2018 Jun; 8(3):143-150. PubMed ID: 29943692
[TBL] [Abstract][Full Text] [Related]
16. Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis.
Kremer TR; Van Dillen LR; Wagner JM
J Rehabil Res Dev; 2014; 51(6):975-84. PubMed ID: 25356797
[TBL] [Abstract][Full Text] [Related]
17. Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial.
Paoloni M; Giovannelli M; Mangone M; Leonardi L; Tavernese E; Di Pangrazio E; Bernetti A; Santilli V; Pozzilli C
Clin Rehabil; 2013 Sep; 27(9):803-12. PubMed ID: 23543344
[TBL] [Abstract][Full Text] [Related]
18. Spasticity, gait, and balance in patients with multiple sclerosis: A cross-sectional study.
Norbye AD; Midgard R; Thrane G
Physiother Res Int; 2020 Jan; 25(1):e1799. PubMed ID: 31287210
[TBL] [Abstract][Full Text] [Related]
19. Spasticity, ataxia and fatigue in multiple sclerosis.
Kesselring J; Thompson AJ
Baillieres Clin Neurol; 1997 Oct; 6(3):429-45. PubMed ID: 10101582
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
